Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-7 activates intestinal lymphocytes

M Bilenker1, A I Roberts, R E Brolin

  • 1Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019, USA.

Digestive Diseases and Sciences
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.

Oncogene·2015
Same author

The interaction between mesenchymal stem cells and steroids during inflammation.

Cell death & disease·2014
Same author

Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species.

Cell death and differentiation·2013
Same author

A novel subset of helper T cells promotes immune responses by secreting GM-CSF.

Cell death and differentiation·2013
Same author

p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation.

Oncogene·2013
Same author

GRO is Chemotactic for Human Intestinal Intraepithelial Lymphocytes.

Inflammatory bowel diseases·2013
Same journal

Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease.

Digestive diseases and sciences·2026
Same journal

Development and Validation of a Crotonylation-Related Prognostic Risk Model for Cholangiocarcinoma Based on Integrative Transcriptome Analysis.

Digestive diseases and sciences·2026
Same journal

Cardiac Arrests During Inpatient Gastrointestinal Endoscopic Procedures: A United States Nationwide Assessment.

Digestive diseases and sciences·2026
Same journal

Standardizing Transition of Care for Adolescents with Inflammatory Bowel Disease: The Need for a Unified Approach.

Digestive diseases and sciences·2026
Same journal

Rapid Gastric Emptying: Insights from a Large Cohort Study on a Controversial Disorder.

Digestive diseases and sciences·2026
Same journal

Readability, Quality, Understandability, and Actionability of ChatGPT Generated GI Patient Education Versus AGA Patient Center.

Digestive diseases and sciences·2026
See all related articles

Human intestinal lymphocytes show minimal proliferation in vitro. Interleukin-7 (IL-7) significantly enhances intestinal lymphocyte growth, unlike IL-9 or IL-12, suggesting a key role for IL-7 in immune responses.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Human intestinal lymphocytes, especially intraepithelial lymphocytes, exhibit limited proliferation in vitro.
  • This reduced proliferation may stem from the absence of crucial in vivo factors.

Purpose of the Study:

  • To investigate the effects of three T-cell growth factors (IL-7, IL-9, and IL-12) on human intestinal lymphocyte proliferation.
  • To determine if these factors can overcome the limited in vitro proliferative capacity.

Main Methods:

  • Testing the proliferative response of intraepithelial lymphocytes and lamina propria lymphocytes to IL-7, IL-9, and IL-12.
  • Assessing the role of IL-2 signaling via IL-2 receptors and CD3 pathway stimulation.
  • Analyzing the response of CD4+, CD8+, T-cell receptor alpha beta, and gamma delta subsets.

Related Experiment Videos

Main Results:

  • Both intraepithelial and lamina propria lymphocytes proliferated more robustly in response to IL-7 compared to IL-9 or IL-12.
  • IL-7 uniquely enhanced CD3 pathway stimulation, indicating a specific role in T-cell activation.
  • The IL-7-induced proliferation was dependent on IL-2 signaling, with IL-2 receptors expressed on intestinal lymphocytes.
  • All tested T-cell subsets (CD4+, CD8+, TCR αβ, TCR γδ) responded to IL-7.

Conclusions:

  • Interleukin-7 (IL-7) selectively promotes the proliferation of human intestinal lymphocytes, including intraepithelial lymphocytes and lamina propria lymphocytes.
  • This IL-7-driven proliferation is IL-2 dependent and enhances T-cell receptor-mediated activation.
  • IL-7 represents a promising factor for potentially enhancing intestinal immune cell growth and function in vivo.